Markets Stocks Economy Crypto Earnings Banking Energy
Home Markets Feature
Markets · Exclusive

European ADRs drift higher as energy and biotech lead a quiet session

European ADRs drift higher as energy and biotech lead a quiet session
Markets · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Sep 1, 2026 4 min read

European companies that trade on US exchanges as American depositary receipts (ADRs) were barely higher late Tuesday morning, with the S&P Europe Select ADR Index inching up 0.05% to 1,953.79. The move was led by energy shares and a few biotech names, while some of the region's biggest technology and telecom stocks slipped.

What's driving the market?

A near-flat index day usually means investors are picking spots rather than making a broad bet on Europe. That was the case Tuesday, as travel site trivago led the gainers, up 5.6%, while energy shares like Equinor (+1.8%) and BP (+2.4%) helped keep the benchmark in the green. Biotech was choppy: Mereo BioPharma Group jumped 5.4% and Grifols added 1%, but DBV Technologies fell 4% and Trinity Biotech and NuCana each dropped 2.1%.

The energy strength comes as oil prices have been volatile recently, with geopolitical tensions and supply concerns pushing crude higher. That tends to lift the shares of oil and gas producers, which are a heavy weight in European indices. For investors, a rising energy sector can be a double-edged sword: it boosts the stocks of producers but can also feed into higher inflation and weigh on consumer spending.

On the downside, Nokia and SAP slipped. Nokia, the Finnish telecom equipment maker, has been under pressure as demand for 5G gear slows in some markets. SAP, the German software giant, is a bellwether for European tech, and its decline suggests investors are cautious about the sector's near-term outlook, especially with interest rates still elevated.

What are ADRs and why do they matter?

American depositary receipts are a way for US investors to buy shares of foreign companies without dealing with foreign exchanges or currency conversions. Each ADR represents a certain number of shares in the underlying company, and they trade on US exchanges just like domestic stocks. The S&P Europe Select ADR Index tracks a basket of these, giving a snapshot of how European equities are performing in the US market.

For everyday investors, ADRs offer a convenient way to diversify internationally. But they come with their own risks, including currency fluctuations and sometimes lower liquidity than the home-market shares. A flat day like Tuesday suggests that investors are not making big moves in either direction, which can be a sign of caution.

What it means for investors

The lack of a clear trend in European ADRs points to a market that is waiting for direction. Investors are likely watching several key factors: the path of interest rates, inflation data, and the health of the global economy. Recent data showed eurozone inflation ticking up to 3.3%, driven by high energy costs, which could keep pressure on the European Central Bank to maintain higher rates for longer.

Higher rates tend to hurt growth stocks, like tech and biotech, because they reduce the present value of future earnings. That may explain why SAP and some biotech names slipped even as the broader index held up. Energy stocks, on the other hand, often benefit from higher oil prices, which can be a hedge against inflation.

For investors with exposure to European ADRs, the takeaway is that the market is not moving in one direction. It's a stock-picker's environment, where company-specific news and sector trends matter more than the overall index. If you're considering adding European exposure, it's worth looking at the underlying fundamentals of each company rather than just the regional trend.

Also worth noting: the dollar's strength plays a role. A stronger dollar makes European ADRs more valuable in dollar terms, but it can also hurt European exporters by making their goods more expensive abroad. The dollar has been edging higher as traders await key US data, which could add to the mixed picture.

Looking ahead

Investors will be watching upcoming economic data and central bank meetings for clues about the direction of interest rates. The energy sector's strength could continue if oil prices stay elevated, but that also raises the risk of higher inflation and tighter monetary policy. For now, the European ADR market is treading water, and that may be the most telling signal of all.

More from this story

Next article · Don't miss

Chip and pharma projects could lift US factory construction above $200B

UBS expects US factory construction to rebound, led by new chip and pharma projects. Manufacturing-related building could top $200 billion by end of next year after a recent slowdown.

Read the story →
Chip and pharma projects could lift US factory construction above $200B